Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Arvida Group Ltd

ARV:NZC

Arvida Group Ltd

Actions
Health CareHealth Care Providers
  • Price (NZD)0.91
  • Today's Change-0.01 / -1.09%
  • Shares traded98.94k
  • 1 Year change-26.61%
  • Beta1.1644
Data delayed at least 20 minutes, as of Jun 18 2024 06:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 15-Jun-23
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
  • 13-Jun-24
Select bar for recommendation details.
Recommendations13-Jun-24
Buy0
Outperform2
Hold3
Underperform0
Sell0

Share price forecast in NZD

The 5 analysts offering 12 month price targets for Arvida Group Ltd have a median target of 1.30, with a high estimate of 1.68 and a low estimate of 1.16. The median estimate represents a 42.86% increase from the last price of 0.91.
High84.6%1.68
Med42.9%1.30
Low27.5%1.16

Dividends

Historical dividend information is not available for Arvida Group Ltd.
Div growth (TTM)--
More ▼

Earnings history & estimates in NZD

Arvida Group Ltd reported annual 2024 earnings of 0.117 per share on May 27, 2024.
Average growth rate+4.51%
More ▼

Revenue history & estimates in NZD

Arvida Group Limited had revenues for the full year 2024 of 247.16m. This was 11.34% above the prior year's results.
Average growth rate+10.90%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.